Cyantraniliprole and cyromazine compounded insecticide
A technology of cyantraniliprole and insecticide, which is applied in the field of compounding two insecticides, can solve the problems of enhancement and reduction, and achieve the effects of prolonging the life cycle, reducing the cost of use, and reducing pollution
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0015] Example 1 Indoor Joint Toxicity Assay
[0016] The tested insect source Pierisrapae Linne was collected from the cabbage field of Heping Village, Furong District, Changsha City, Hunan Province, and raised indoor with hydroponic cabbage seedlings. Each worm state is kept at (28±l)°C, the photoperiod is 14h / 10h (light / dark), and the ambient humidity is RH50%~75% in the entomology room, and the 3rd generation and 3rd instar larvae are kept for later use.
[0017] Instruments and equipment, test agents
[0018] Electronic balance (sensitivity 0.1 mg); glass slide; capillary; filter paper; brush; petri dish with a diameter of 9 cm; beaker; pipette; tweezers, etc.;
[0019] 98% cyromazine original drug;
[0020] 94% cyantraniliprole (cyantraniliprole) technical;
[0021] First, dissolve and dilute appropriate amount of the original drug and the different ratios of the two original drugs with acetone to form 5 series of concentration gradients for use. Cyromazine was dilut...
Embodiment 2
[0036] Embodiment 2 suspending agent
[0037] Active ingredient formula: 3% cyromazine, 3% cyantraniliprole, 2% fatty alcohol ethoxylates, 1% sodium methylene bis-tetrasulfonate, 1.3% calcium dodecylbenzenesulfonate, 3% Tristyrylphenol polyoxyethylene ether, 1.5% white carbon black, 0.25% xanthan gum, the rest is made up with water, and prepared according to the conventional production method of suspending agent. The percentages all refer to mass percentages.
Embodiment 3-9
[0038] Embodiment 3-9 suspending agent
[0039]According to the method similar to Example 1, the suspending agent is made, and the auxiliary components are the same, but the active ingredient formula is slightly different, as follows:
[0040] Table 3 embodiment formula table
[0041]
PUM

Abstract
Description
Claims
Application Information

- Generate Ideas
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com